Infliximab
Treatment used for 5 conditions
Total Trials
584
Total Participants
101K
Avg Effectiveness
78%
Avg Safety Score
48%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.
Inflammatory bowel disease
Effectiveness:83%
Safety:55%
Trials:259
Participants:50K
Crohn's Disease
Effectiveness:75%
Safety:40%
Trials:176
Participants:30K
Ulcerative Colitis
Effectiveness:80%
Safety:60%
Trials:118
Participants:20K
Interstitial lung disease and pulmonary sarcoidosis
Effectiveness:60%
Safety:35%
Trials:30
Participants:1K
Pyoderma
Effectiveness:90%
Safety:48%
Trials:1
Participants:1K